(Received for publication November 13, 1946) During a program of mass chemoprophylaxis of streptococcal infections in the Armed Forces (1), it was noted that the effectiveness of such a regimen was lost with the appearance of sulfonamide-resistant strains of hemolytic streptococci. The occurrence and spread of these resistant strains in susceptible populations in the U. S. Army and Navy have been reported (2, 3, 4), and have been the subject of considerable speculation and theoretical implications. To Of these cases of drug-resistant infection, 14 were dinical scarlet fever, and 9 were merely pharyngitis. One case of scarlet fever and one case of pharyngitis were complicated by otitis media and one patient developed rheumatic fever following pharyngitis due to this type 19 sulfadiazine-resistant hemolytic streptococcus. None of these cases presented any special therapeutic problems, nor were they clinically different from infections due to other types of hemolytic streptococci. The incidence of infection with this particular organism was rather evenly distributed throughout the period of this study with the peak occurring early (see Figure 1) . COMMENT The possibility of a spread of sulfadiazine-resistant hemolytic streptococci to the civilian population has been anticipated ever since their appearance' in the Armed Forces (2, 3, 4) . The present report indicates that such resistant strains have, indeed, been responsible for infections in at least one civilian community and that similai occurrences may complicate future problems of therapy among civilians.
The mode of development of resistant strains of bacteria is still a matter of discussion. It has been demonstrated that strains of streptococci with low or medium degrees of sulfadiazine resistance appeared in the Army (7) about the time that the program of mass sulfa-prophylaxis had been in progress in the Navy (1) for several months. It had been suggested that these slightly resistant strains were mutants that might possibly have been precursors of the more highly resistant strains later established. The possibility cannot, however, be eliminated that there was a transfer of resistant strains to soldiers from certain Naval personnel, who were subjects of the mass prophylaxis program, and hence possible carriers of highly resistant streptococci. It is noteworthy that no evidence of sulfonamide resistance was found in any strains of hemolytic streptococci prior to the institution of the mass chemoprophylaxis programs (2, 8) .
The possibility that sulfonamide-resistant hemolytic streptococci could arise in the civilian population must be considered. The evidence to date, however, would seem to indicate that all strains of hemolytic streptococci which were present in the civilian population prior to the time of mass chemoprophylaxis in the Armed Forces were susceptible to the action of the sulfonamides. Evidence (8) has also been presented to show that the usual therapeutic doses of sulfonamides, such as might be prescribed in a civilian population, did not cause the development of resistant organisms.
Since the sulfadiazine-resistant hemolytic streptococcal infections reported in this study were caused by a type 19 strain, which was known to be a prominent resistant strain in the Armed Forces, it seems probable that this strain was introduced into this civilian community by military personnel even though a history of recent contact with sick soldiers and sailors could not be elicited. Contact of civilians with discharged veterans, some of whom might have been healthy carriers of these resistant strains, could hardly have been avoided. The fact that most cases of sulfonamide-resistant infections here reported occurred among school children is noteworthy, since all previous reports of sulfonamide-resistant infections occurred in adults.
Although the cases mentioned in this report did not offer any problems as to therapy, one cannot overlook the importance of determining whether one is dealing with an organism sensitive to the chemotherapeutic agent being administered. Since the clinical picture of infections caused by resistant strains of hemolytic streptococci is no different than those caused by non-resistant strains, one can only determine this property by isolation and testing of the organism causing the infection. From an epidemiological and clinical point of view, the determination of the presence of resistant strains would be of definite value if the prevention and treatment of resistant-strain complications is to be effectively accomplished.
The appearance of increasing numbers of bacteria which are resistant to various chemotherapeutic agents, formerly effective against them, suggests the desirability of a careful bacteriological diagnosis of infectious agents prior to treatment with specific antibacterial drugs, especially when there is an obvious failure of clinical response to the chemotherapeutic agent under consideration.
SUM MARY
Twenty-three cases of type 19 sulfadiazine-resistant hemolytic streptococcus infections occurred in a civilian community. None of the cases presented any problem as to treatment nor were there any serious complications. Attention is directed to the importance of determining the sensitivity of infecting bacteria to chemotherapeutic agents prior to the start of treatment with specific agents.
